NASDAQ:APLT

Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025)

Applied Therapeutics shares fell about 35% premarket to $0.14 after announcing a deal to be acquired by Cycle Pharmaceuticals. The offer includes $0.088 per share in cash and a non-transferable contingent value right tied to future FDA approvals and sales milestones. The transaction is expected to close in Q1 2026, pending a majority tender. No financing condition is attached to the merger.

12 December 2025

Biotechnology·NASDAQ:APLT·Pharmaceutical News·Stock Market

Applied Therapeutics (APLT) Stock Explodes on Heavy Volume as FDA Scrutiny and Cash Concerns Collide – November 17, 2025

Applied Therapeutics shares surged up to 70% on November 17, 2025, with trading volume exceeding 40 million shares after Q3 results showed a narrower net loss but cash fell to $11.9 million. Regulatory uncertainty over its lead drug and ongoing legal issues remain unresolved. Analysts are split on the company’s ability to survive without new funding or a partner.

17 November 2025

Biotechnology·NASDAQ:APLT

Toromont Industries Shares Surpass 200-Day Moving Average Amid Analyst Upgrades
March 20, 2026, 3:37 AM EDT. Toromont Industries Ltd. (TSE:TIH) stock traded above its 200-day moving average of C$170.27 on Thursday, hitting a high of C$196.50. The company boasts a market cap of C$15.69 billion and a price-to-earnings ratio of 31.74. Notably, five analysts maintain a Buy rating, with the average price target raised to C$198.63. Recent earnings showed a C$1.92 earnings per share (EPS) on C$1.42 billion revenue. Toromont also increased its quarterly dividend to C$0.56 per share, yielding 1.2%. Insider activity included a sale of 972 shares at C$201.60 each. The firm's improving fundamentals and upward analyst revisions highlight growing investor confidence in the stock.